Cite
Ziemssen F, Wachtlin J, Kuehlewein L, et al. Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany. Diabetes Ther. 2018;9(6):2271-2289doi: 10.1007/s13300-018-0513-2.
Ziemssen, F., Wachtlin, J., Kuehlewein, L., Gamulescu, M. A., Bertelmann, T., Feucht, N., Voegeler, J., Koch, M., Liakopoulos, S., Schmitz-Valckenberg, S., Spital, G. (2018). Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany. Diabetes therapy : research, treatment and education of diabetes and related disorders, 9(6), 2271-2289. https://doi.org/10.1007/s13300-018-0513-2
Ziemssen, Focke, et al. "Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 9,6 (2018): 2271-2289. doi: https://doi.org/10.1007/s13300-018-0513-2
Ziemssen F, Wachtlin J, Kuehlewein L, Gamulescu MA, Bertelmann T, Feucht N, Voegeler J, Koch M, Liakopoulos S, Schmitz-Valckenberg S, Spital G. Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany. Diabetes Ther. 2018 Dec;9(6):2271-2289. doi: 10.1007/s13300-018-0513-2. Epub 2018 Oct 04. PMID: 30288700; PMCID: PMC6250630.
Copy
Download .nbib